These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10668600)

  • 1. [Selective attention and schizophrenia before the administration of neuroleptics].
    Lussier I; Stip E
    Encephale; 1999; 25(6):576-83. PubMed ID: 10668600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical neuroleptics and selective attention].
    Stip E; Lussier I; Lalonde P; Luyet A; Fabian J
    Encephale; 1999; 25(3):260-4. PubMed ID: 10434152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear distinction between preattentive and attentive process in schizophrenia by visual search performance.
    Tanaka G; Mori S; Inadomi H; Hamada Y; Ohta Y; Ozawa H
    Psychiatry Res; 2007 Jan; 149(1-3):25-31. PubMed ID: 17123633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preattentional processes and disorganization in schizophrenia: Influence of a 6-week risperidone treatment.
    Amado I; Bourdel MC; Daban C; Poirier MF; Loo H; Bouhours P; Krebs MO
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1107-12. PubMed ID: 19527763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is filtering difficulty the basis of attentional deficits in schizophrenia?
    Ravizza SM; Robertson LC; Carter CS; Nordahl TE; Salo RE
    Psychiatry Res; 2007 Jun; 151(3):201-9. PubMed ID: 17399801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual search performance among persons with schizophrenia as a function of target eccentricity.
    Elahipanah A; Christensen BK; Reingold EM
    Neuropsychology; 2010 Mar; 24(2):192-8. PubMed ID: 20230113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Deficit in suppression of interference in visual information processing by schizophrenic subjects].
    Gagnon JF; Everett J; LaJeunesse C; Gosselin N; Lavoie K
    Encephale; 2000; 26(2):56-62. PubMed ID: 10858917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive and negative spatial priming in schizophrenia.
    Zimmermann M; Stark R; Kern G; Laiacker M; Kirsch P; Vaitl D
    J Clin Exp Neuropsychol; 2006 Jul; 28(5):706-20. PubMed ID: 16723319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptics reverse attentional effects in schizophrenia patients.
    Sapir A; Dobrusin M; Ben-Bashat G; Henik A
    Neuropsychologia; 2007 Nov; 45(14):3263-71. PubMed ID: 17688893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The remains of the trial: goal-determined inter-trial suppression of selective attention.
    Lleras A; Levinthal BR; Kawahara J
    Prog Brain Res; 2009; 176():195-213. PubMed ID: 19733758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attention impairment in patients suffering from schizophrenia and their relatives of first-degree].
    Hintze B; Kühn-Dymecka A; Bembenek A; Wrońska A; Wciórka J
    Psychiatr Pol; 2004; 38(5):861-73. PubMed ID: 15523932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia.
    Hutton SB; Crawford TJ; Gibbins H; Cuthbert I; Barnes TR; Kennard C; Joyce EM
    Psychopharmacology (Berl); 2001 Sep; 157(3):284-91. PubMed ID: 11605084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Saccadic reaction times and visuospatial disorders of attention in schizophrenic patients with negative symptoms].
    Mackert A; Flechtner M; Frick K
    Fortschr Neurol Psychiatr; 1989 Dec; 57(12):535-43. PubMed ID: 2613156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive inhibition and psychopathology: toward a less simplistic conceptualization].
    Everett J; Lajeunesse C
    Encephale; 2000; 26(2):13-20. PubMed ID: 10858910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First month of neuroleptic treatment in schizophrenia: only partial normalization of the late positive components of visual ERP.
    Mintz M; Hermesh H; Glicksohn J; Munitz H; Radwan M
    Biol Psychiatry; 1995 Mar; 37(6):402-9. PubMed ID: 7772649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients].
    Bralet MC; Yon V; Loas G; Noisette C
    Encephale; 2000; 26(6):32-41. PubMed ID: 11217537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.